Journal article
Identification and characterization of CD4+ T cell epitopes after Shingrix vaccination
Journal of Virology, Vol.94(24)
2020
Abstract
Infections with varicella-zoster virus (VZV) are associated with a range of clinical manifestations. Primary infection with VZV causes chicken pox. The virus remains latent in neurons, and it can reactivate later in life, causing herpes zoster (HZ). Two different vaccines have been developed to prevent HZ; one is based on a live attenuated VZV strain (Zostavax), and the other is based on adjuvanted gE recombinant protein (Shingrix). While Zostavax efficacy wanes with age, Shingrix protection retains its efficacy in elderly subjects (individuals 80 years of age and older). In this context, it is of much interest to understand if there is a role for T cell immunity in the differential clinical outcome and if there is a correlate of protection between T cell immunity and Shingrix efficacy. In this study, we characterized the Shingrix-specific ex vivo CD4 T cell responses in the context of natural exposure and HZ vaccination using pools of predicted epitopes. We show that T cell reactivity following natural infection and Zostavax vaccination dominantly targets nonstructural (NS) proteins, while Shingrix vaccination redirects dominant reactivity to target gE. We mapped the gE-specific responses following Shingrix vaccination to 89 different gE epitopes, 34 of which accounted for 80% of the response. Using antigen presentation assays and single HLA molecule-transfected lines, we experimentally determined HLA restrictions for 94 different donor/peptide combinations. Finally, we used our results as a training set to assess strategies to predict restrictions based on measured or predicted HLA binding and the corresponding HLA types of the responding subjects.
Details
- Title
- Identification and characterization of CD4+ T cell epitopes after Shingrix vaccination
- Authors/Creators
- H. Voic (Author/Creator) - La Jolla Institute for ImmunologyR.D. de Vries (Author/Creator) - La Jolla Institute for ImmunologyJ. Sidney (Author/Creator) - La Jolla Institute for ImmunologyP. Rubiro (Author/Creator) - La Jolla Institute for ImmunologyE. Moore (Author/Creator) - La Jolla Institute for ImmunologyE. Phillips (Author/Creator) - Murdoch UniversityS. Mallal (Author/Creator) - Murdoch UniversityB. Schwan (Author/Creator) - La Jolla Institute for ImmunologyD. Weiskopf (Author/Creator) - La Jolla Institute for ImmunologyA. Sette (Author/Creator) - La Jolla Institute for ImmunologyA. Grifoni (Author/Creator) - La Jolla Institute for ImmunologyF. Goodrum (Author/Creator)
- Publication Details
- Journal of Virology, Vol.94(24)
- Publisher
- American Society for Microbiology
- Identifiers
- 991005542154907891
- Copyright
- © 2020 American Society for Microbiology
- Murdoch Affiliation
- Institute for Immunology and Infectious Diseases
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
44 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.161 Virology - Identification & Sequencing
- 1.161.315 Herpesvirus Dynamics
- Web Of Science research areas
- Virology
- ESI research areas
- Microbiology